A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
Across-the-board inflation — including food costs, labor costs, and real estate costs — is pummeling restaurants. Can the industry survive?
In 2024, legacy media giants like Disney and NBCUniversal finally had enough with cable — and started making their own off-ramps.
YouTube may have started off as a platform for small screens, but now it’s increasingly dominating the living room TV.